Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome

scientific article published on 20 June 2012

Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1015476071
P356DOI10.1007/S00467-012-2228-3
P698PubMed publication ID22714672

P2093author name stringDayan Wang
Wenjing Wang
Jianhua Mao
Lizhong Du
Yonghui Xia
Yifang Chen
Haidong Fu
Huijun Shen
Ai'min Liu
P2860cites workExpression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathyQ33255769
Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndromeQ33387197
Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndromeQ36153584
Experience with tacrolimus in children with steroid-resistant nephrotic syndromeQ37229944
Interaction of calcineurin with substrates and targeting proteinsQ37813260
Safety and efficacy of tacrolimus in pediatric liver recipientsQ37822906
Macrophage depletion attenuates chronic cyclosporine A nephrotoxicityQ43035799
Long-term follow-up of co-administration of diltiazem and cyclosporine in Chinese kidney transplant recipientsQ43108543
Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimusQ43136060
Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-upQ43935632
Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.Q44772814
Renal interstitial fibrosis in children treated with FK506 for nephrotic syndromeQ44853317
Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapyQ45126690
Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trialQ46096920
Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experienceQ46705142
Short- and long-term efficacy of levamisole as adjunctive therapy in childhood nephrotic syndrome.Q46801483
Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimusQ46823230
Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in childrenQ46881412
Ketoconazole-tacrolimus coadministration in kidney transplant recipients: two-year results of a prospective randomized study.Q46952935
Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.Q51554491
The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescentsQ69035747
NPHS1 and NPHS2 gene mutations in Chinese children with sporadic nephrotic syndromeQ79519771
Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreatedQ80341030
Lack of association between NPHS2 gene polymorphisms and sporadic IgA nephropathyQ80627679
Clinical evaluation of chronic nephrotoxicity of long‐term cyclosporine A treatment in adult patients with steroid‐dependent nephrotic syndromeQ82458069
Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndromeQ83602335
P433issue11
P921main subjectcyclosporineQ367700
nephrotic syndromeQ504790
idiopathic nephrotic syndromeQ55787775
P304page(s)2073-2079
P577publication date2012-06-20
P1433published inPediatric NephrologyQ15749796
P1476titleTreatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome
P478volume27

Reverse relations

cites work (P2860)
Q53702610Calcineurin inhibitors and nephrotoxicity in children.
Q37223452Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models
Q50417540Efficacy and Safety of Cyclosporine versus Tacrolimus in Steroid and Cyclophosphamide Resistant Nephrotic Syndrome: A Prospective Study.
Q89137674Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome: A Randomized Clinical Trial
Q90102684Efficacy of plasma exchange with a high dose of acyclovir for disseminated varicella infection
Q37427201Efficacy of triptolide for children with moderately severe Henoch-Schönlein purpura nephritis presenting with nephrotic range proteinuria: a prospective and controlled study in China
Q39827261Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children
Q52945061Minimal Change Disease.
Q24202861Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children
Q64111320Population pharmacokinetics of tacrolimus in pediatric refractory nephrotic syndrome and a summary of other pediatric disease models
Q87407965Serum suPAR levels help differentiate steroid resistance from steroid-sensitive nephrotic syndrome in children
Q51292313Tacrolimus for children with refractory nephrotic syndrome: a one-year prospective, multicenter, and open-label study of Tacrobell®, a generic formula.
Q38050961Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO.

Search more.